Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
lung disease
|
| gptkbp:advertising |
increased through campaigns
|
| gptkbp:associated_with |
rheumatoid arthritis
scleroderma systemic lupus erythematosus |
| gptkbp:causedBy |
scarring of lung tissue
|
| gptkbp:clinicalTrials |
fatigue
weight loss clubbing of fingers investigating new therapies assessing gene therapy dry crackling sound in lungs evaluating stem cell therapy progressive dyspnea testing antifibrotic agents |
| gptkbp:complications |
gptkb:pulmonary_hypertension
respiratory failure |
| gptkbp:demographics |
more common in older adults
affects both men and women |
| gptkbp:diseaseResistance |
varies by individual
high-resolution CT scan lung_biopsy |
| gptkbp:feedback |
requires ongoing monitoring
can be managed with treatment improved with early diagnosis may lead to lung transplantation |
| gptkbp:funding |
for research is critical
|
| gptkbp:hasService |
blood tests
pulmonary function tests |
| gptkbp:healthcare |
important for management
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pulmonary fibrosis
|
| gptkbp:impact |
lungs
medications pulmonary rehabilitation oxygen therapy |
| gptkbp:inheritsFrom |
familial_pulmonary_fibrosis
|
| gptkbp:is_a_route_for |
disruption of normal lung architecture
excessive collagen deposition inflammation of lung tissue |
| gptkbp:performances |
based on severity
involves functional assessment radiological findings |
| gptkbp:personalLife |
regular exercise
healthy diet avoiding pollutants quitting smoking |
| gptkbp:research |
ongoing clinical trials
|
| gptkbp:riskManagement |
smoking
exposure to environmental pollutants |
| gptkbp:supports |
available for patients
|
| gptkbp:symptoms |
shortness of breath
chronic cough |
| gptkbp:type |
gptkb:idiopathic_pulmonary_fibrosis
asbestosis sarcoidosis nonspecific interstitial pneumonia |